Multiomic, Plasma-Only ctDNA NGS Assay Developed for Minimal Residual Disease (MRD) Detection in Early-Stage NSCLC

被引：0
|
作者：
Kurata, J. [1 ]
Price, K. [2 ]
Banks, K. [3 ]
Zotenko, E. [3 ]
Dinman, T. [3 ]
Parsana, P. [3 ]
Miao, Z. [3 ]
Ju, J. [3 ]
Hite, D. [3 ]
Cheng, D. [3 ]
Talasaz, A. [3 ]
机构：
[1] Guardant Hlth, Redwood City, AL USA
[2] Guardant Hlth, Redwood City, MA USA
[3] Guardant Hlth, Redwood City, CA USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2021年 / 16卷 / 10期
关键词：
ctDNA; Liquid biopsy; minimal residual disease;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
FP05.03
引用
收藏
页码：S952 / S953
页数：2
相关论文
共 50 条
  • [1] Multiomic, plasma-only ctDNA NGS assay for minimal residual disease (MRD) detection in solid tumors.
    Kurata, Jessica
    Price, Kristin Sedgwick
    Banks, Kimberly
    Zotenko, Elena
    Hite, Dustin
    Cheng, Donavan
    Parsana, Princy
    Ju, Jin Hyun
    Dinman, Tara
    Miao, Zong
    Talasaz, AmirAli
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [2] Multiomic, plasma-only circulating tumor DNA (ctDNA) assay identifies breast cancer patients with minimal residual disease (MRD) and predicts distant recurrence
    Janni, Wolfgang
    Huober, Jens
    Braun, Tatjana
    Mueller, Volkmar
    Fink, Angelina
    de Gregorio, Amelie
    Rack, Brigitte
    Friedl, Thomas W.
    Wiesmueller, Lisa
    Pantel, Klaus
    Rich, Thereasa
    Parsana, Princy
    Zotenko, Elena
    Zhang, Shile
    Huesmann, Sophia
    [J]. CANCER RESEARCH, 2022, 82 (12)
  • [3] Analysis of ctDNA for the detection of minimal residual disease (MRD) using a tissue-free, multiomic assay in patients with early-stage breast cancer
    Janni, Wolfgang
    Friedl, Thomas
    Rack, Brigitte
    Fasching, Peter A.
    Hartkopf, Andreas
    Tesch, Hans
    Lorenz, Ralf
    Heinrich, Georg
    Blohmer, Jens-Uwe
    Fehm, Tanja
    Mueller, Volkmar
    Schneeweiss, Andreas
    Beckmann, Matthias
    Ruebner, Matthias
    Harbeck, Nadia
    Pantel, Klaus
    Dustin, Derek
    Cai, Mingyang
    [J]. CANCER RESEARCH, 2024, 84 (09)
  • [4] Minimal residual disease (MRD) detection in colorectal cancer (CRC) using a plasma-only integrated genomic and epigenomic circulating tumor DNA (ctDNA) assay
    Parikh, A.
    van Seventer, E.
    Boland, G.
    Siravegna, G.
    Hartwig, A.
    Jaimovich, A.
    Raymond, V. M.
    Talasaz, A.
    Corcoran, R. B.
    [J]. ANNALS OF ONCOLOGY, 2020, 31 : S419 - S419
  • [5] Clinician utilization of a plasma-only, multiomic minimal residual disease (MRD) assay in 2,000 consecutive patients with colorectal cancer (CRC).
    Pedersen, Katrina Sophia
    Bucheit, Leslie A.
    Tan, Benjamin R.
    Hu, Zishuo Ian
    Shusterman, Michael
    Weipert, Caroline
    Banks, Kimberly
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E15586 - E15586
  • [6] Phylogenetic tracking and minimal residual disease detection using ctDNA in early-stage NSCLC: A lung TRACERx study
    Abbosh, Chris
    Frankell, Alexander
    Garnett, Aaron
    Harrison, Thomas
    Weichert, Morgan
    Licon, Abel
    Veeriah, Selvaraju
    Daber, Bob
    Moreau, Mike
    Chesh, Adrian
    Litchfield, Kevin
    Lim, Emilia
    Cooke, Daniel
    Puttick, Clare
    Al Bakir, Maise
    Gomes, Fabio
    Patel, Akshay
    Manzano, Lizi
    Huebner, Ariana
    Carey, Nicolas
    Riley, Joan
    Roberts, Paula
    Druley, Todd
    Shaw, Jacqui A.
    McGranahan, Nicholas
    Jamal-Hanjani, Mariam
    Birkbak, Nicolai
    Stahl, Josh
    Swanton, Charles
    [J]. CANCER RESEARCH, 2020, 80 (16)
  • [7] Plasma-only ctDNA-Guided MRD Detection in Patients with CRC-Response
    Parikh, Aparna R.
    Corcoran, Ryan B.
    [J]. CLINICAL CANCER RESEARCH, 2021, 27 (23) : 6614 - 6615
  • [8] Plasma-only ctDNA-Guided MRD Detection in Patients with CRC-Letter
    Reinert, Thomas
    V. Henriksen, Tenna
    Aleshin, Alexey
    Zimmermann, Bernhard
    Andersen, Claus Lindbjerg
    [J]. CLINICAL CANCER RESEARCH, 2021, 27 (23) : 6613 - 6613
  • [9] Enhancing detection of ctDNA in patients with early-stage or residual disease
    Rosenfeld, Nitzan
    [J]. CLINICAL CANCER RESEARCH, 2020, 26 (11) : 20 - 20
  • [10] Minimal Residual Disease Detection using a Plasma-only Circulating Tumor DNA Assay in Patients with Colorectal Cancer
    Parikh, Aparna R.
    Van Seventer, Emily E.
    Siravegna, Giulia
    Hartwig, Anna, V
    Jaimovich, Ariel
    He, Yupeng
    Kanter, Katie
    Fish, Madeleine G.
    Fosbenner, Kathryn D.
    Miao, Benchun
    Phillips, Susannah
    Carmichael, John H.
    Sharma, Nihaarika
    Jarnagin, Joy
    Baiev, Islam
    Shah, Yojan S.
    Fetter, Isobel J.
    Shahzade, Heather A.
    Allen, Jill N.
    Blaszkowsky, Lawrence S.
    Clark, Jeffrey W.
    Dubois, Jon S.
    Franses, Joseph W.
    Giantonio, Bruce J.
    Goyal, Lipika
    Klempner, Samuel J.
    Nipp, Ryan D.
    Roeland, Eric J.
    Ryan, David P.
    Weekes, Colin D.
    Wo, Jennifer Y.
    Hong, Theodore S.
    Bordeianou, Liliana
    Ferrone, Cristina R.
    Qadan, Motaz
    Kunitake, Hiroko
    Berger, David
    Ricciardi, Rocco
    Cusack, James C.
    Raymond, Victoria M.
    Talasaz, AmirAli
    Boland, Genevieve M.
    Corcoran, Ryan B.
    [J]. CLINICAL CANCER RESEARCH, 2021, 27 (20) : 5586 - 5594
12345